What happened
Banks leading Anthropic’s IPO have turned away or deem unlikely allocations for investors from mainland China and Hong Kong, invoking U.S. International Traffic in Arms Regulations (ITAR).
According to a Bloomberg report cited by The Decoder, multiple banks involved in Anthropic’s IPO have either rejected or indicated they are unlikely to allocate shares to investors based in mainland China or Hong Kong. The banks cited the United States’ International Traffic in Arms Regulations (ITAR) as the governing reason for the refusal.
Goldman Sachs and Morgan Stanley are the lead underwriters for the offering, with a consortium of 20 additional banks participating. The company is slated to list on the Nasdaq under the ticker "ANT" after pricing on November 18, with trading expected to begin on November 19.
Anthropic has not commented on the allegations. The firm’s AI products, including its Claude series, are not officially available in China or Hong Kong, and the company has previously blocked Chinese‑controlled firms from accessing its services. It has also taken steps to combat workarounds that allow Chinese entities to use Claude Code, and it publicly disclosed large‑scale attacks by competitors such as DeepSeek, Moonshot, and MiniMax.
The banks’ reliance on ITAR reflects the of certain AI technologies as defense‑related items under U.S. law. ITAR restrictions prohibit the export of controlled items to designated foreign persons or regions without a license, and financial institutions must ensure compliance when allocating securities.
Source details: the-decoder.com
Why it matters
The restriction highlights how U.S. export‑control policy can shape capital flows into high‑profile AI companies, potentially limiting foreign participation in one of the sector’s biggest public offerings and signaling heightened regulatory scrutiny for AI firms with defense‑related technology components.
Export‑control regimes like ITAR are increasingly intersecting with the AI sector, where models can be deemed dual‑use technologies. By restricting Chinese and Hong Kong investors, banks are signaling that compliance risk outweighs potential capital inflow, which could set a precedent for future AI IPOs and secondary offerings.
The move may dampen demand for Anthropic’s shares, potentially influencing pricing and valuation. Investors from other regions may reassess exposure to AI firms that could face similar regulatory barriers, affecting market sentiment toward the broader AI industry.
For Chinese and Hong Kong investors, the restriction reduces direct participation in a high‑visibility AI investment, potentially pushing them toward indirect exposure via global funds or secondary markets, which may carry higher fees or less transparency.
The episode underscores the broader geopolitical tension between the United States and China over AI technology, reinforcing the notion that AI companies must navigate not only market competition but also national security considerations.
Interactive Mechanism: How It Actually Works
Explore the underlying technology behind this development interactively.
Why can ethical evaluation not be reduced to one model score?
What to watch next
Future guidance from the U.S. Department of State on AI‑related export controls, Anthropic’s ability to secure broader investor demand, and any legal challenges or policy adjustments that could affect subsequent AI IPOs.
Any official clarification or amendment from the U.S. State Department regarding the scope of ITAR as it applies to AI models and related services.
Anthropic’s subsequent communications about its compliance strategy and whether it will seek licenses to broaden investor eligibility.
Potential legal challenges from excluded investors or advocacy groups arguing that the restrictions constitute unfair market discrimination.
The reaction of other AI firms planning IPOs or secondary offerings, which may pre‑emptively adjust their investor outreach strategies to avoid similar export‑control complications.